Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis
Authors
Keywords
Autologous stem cell transplantation, FDG-PET, Hodgkin lymphoma, Meta-analysis, Systematic review
Journal
ANNALS OF HEMATOLOGY
Volume 95, Issue 5, Pages 695-706
Publisher
Springer Nature
Online
2016-03-02
DOI
10.1007/s00277-016-2619-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study
- (2015) Alison J Moskowitz et al. LANCET ONCOLOGY
- F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma
- (2014) Ryan D. Gentzler et al. BRITISH JOURNAL OF HAEMATOLOGY
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
- (2014) Sally F. Barrington et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessing Bias in Studies of Prognostic Factors
- (2013) Jill A. Hayden et al. ANNALS OF INTERNAL MEDICINE
- Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation†
- (2013) C. Martínez et al. ANNALS OF ONCOLOGY
- Simplified Validated Prognostic Model for Progression-Free Survival after Autologous Transplantation for Hodgkin Lymphoma∗
- (2013) Theresa Hahn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin’s lymphoma: outcome after high-dose chemotherapy and auto-SCT
- (2013) S Akhtar et al. BONE MARROW TRANSPLANTATION
- An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax
- (2013) Emmanuel Itti et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers
- (2013) A. Biggi et al. JOURNAL OF NUCLEAR MEDICINE
- Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome
- (2012) Yago Nieto et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy
- (2012) R. Devillier et al. HAEMATOLOGICA
- High-dose chemotherapy in relapsed or refractory Hodgkin lymphoma patients: a reappraisal of prognostic factors
- (2012) E Cocorocchio et al. HEMATOLOGICAL ONCOLOGY
- Hodgkin Lymphoma: Protecting the Victims of Our Success
- (2012) Bruce D. Cheson JOURNAL OF CLINICAL ONCOLOGY
- Early post-transplantation positron emission tomography in patients with Hodgkin lymphoma is an independent prognostic factor with an impact on overall survival
- (2011) Gülsan Türköz Sucak et al. ANNALS OF HEMATOLOGY
- Prognostic Significance of FDG-PET in Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Standard Salvage Chemotherapy and Autologous Stem Cell Transplantation
- (2011) Jacob P. Smeltzer et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma
- (2011) C. H. Moskowitz et al. BLOOD
- Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma
- (2011) Heidi Mocikova et al. LEUKEMIA & LYMPHOMA
- Phase I/II Trial of GN-BVC, a Gemcitabine and Vinorelbine-Containing Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Recurrent and Refractory Hodgkin Lymphoma
- (2010) Sally Arai et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Dose Intensity of Chemotherapy in Patients With Relapsed Hodgkin's Lymphoma
- (2010) Andreas Josting et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapy
- (2009) Luca Castagna et al. BRITISH JOURNAL OF HAEMATOLOGY
- Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma
- (2009) Alison J. Moskowitz et al. BRITISH JOURNAL OF HAEMATOLOGY
- Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma
- (2008) B. Sirohi et al. ANNALS OF ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started